Toward Guideline-Directed Medical Therapy in Nephrology: Lifetime Benefit of RAAS and SGLT2 Inhibition in Nondiabetic Kidney Disease : Clinical Journal of the American Society of Nephrology

Journal Logo

Editorial

Toward Guideline-Directed Medical Therapy in Nephrology

Lifetime Benefit of RAAS and SGLT2 Inhibition in Nondiabetic Kidney Disease

Zeitler, Evan M.; Mottl, Amy K.

Author Information
CJASN 17(12):p 1710-1712, December 2022. | DOI: 10.2215/CJN.12401022
Copyright © 2022 by the American Society of Nephrology

Full Text Access for Subscribers:

You can read the full text of this article if you:

Access through Ovid